Suchergebnisse - "Wilfong, Lalan S"

PubPharm (11)

1

Drug Shortages in Oncology : ASCO Clinical Guidance for Alternative Treatments

enthalten in: JCO oncology practice | 2024

von Santos, E. | Oliver, T. | Lacchetti, C. | +4

2

Secret Sauce-How Diverse Practices Succeed in Centers for Medicare & Medicaid Services Oncology Care Model

enthalten in: JCO oncology practice | 2021

von Kline, R. | Blau, S. | Buescher, N. | +5

3

Oncology Care Model : A Herculean Effort With Fixable Fatal Flaws

enthalten in: JCO oncology practice | 2021

von Dreyer, T. | Wilfong, L. | Patel, K. | +2

CommentOn: JCO Oncol Pract. 2021 Apr;17(4):169-172. - PMID 33539197

4

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma

enthalten in: Cancer chemotherapy and pharmacology | 2012

von De Jesus-Acosta, A. | Oliver, G. | Blackford, A. | +10

5

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma

enthalten in: Cancer chemotherapy and pharmacology | 2011

von De Jesus-Acosta, A. | Oliver, G. | Blackford, A. | +10

6

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma

enthalten in: Cancer chemotherapy and pharmacology | 2011

von De Jesus-Acosta, A. | Oliver, G. | Blackford, A. | +10

7

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma

enthalten in: Cancer chemotherapy and pharmacology | 2011

von De Jesus-Acosta, A. | Oliver, G. | Blackford, A. | +10

8

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer : results of a phase II, randomized, noncomparative study

enthalten in: Investigational new drugs | 2011

von Richards, D. | Kuefler, P. | Becerra, C. | +12

9

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study

enthalten in: Investigational new drugs | 2009

von Richards, D. | Kuefler, P. | Becerra, C. | +12

10

Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study

enthalten in: Investigational new drugs | 2009

von Richards, D. | Kuefler, P. | Becerra, C. | +12